Biotechnology VALUE FUND II L.P., 10% Owner, Director at INFINITY PHARMACEUTICALS, INC. (INFI), bought 335,127 shares at $1.18 ($396K) on 2016-12-01, disclosed to the SEC on 2016-12-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.18 | 15,161 | $18K | 4.5% |
| 2 | $1.18 | 52,457 | $62K | 15.6% |
| 3 | $1.18 | 52,457 | $62K | 15.6% |
| 4 | $1.18 | 81,276 | $96K | 24.2% |
| 5 | $1.18 | 81,276 | $96K | 24.2% |
| 6 | $1.19 | 2,916 |
| $3K |
| 0.9% |
| 7 | $1.19 | 18,586 | $22K | 5.6% |
| 8 | $1.19 | 30,998 | $37K | 9.3% |
| Total | $1.18 avg | 335,127 | $396K | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |